Panel Discussion: Acting on Molecular Progression to Improve Therapeutic Decision Making Before Imaging Detects Resistance
9:30 am - Thursday 18th March 2027
- Determining how much molecular change justifies a switch when the scan still reads stable
- Weighing the risk of switching too early against the cost of waiting for radiographic confirmation
- Establishing what evidence oncologists and payers need before molecular progression becomes an accepted trigger
